iPSC Core Services

For a full list of services offered by the Human iPSC Core, please visit the iLab website. 

Important:

  1. All UPenn users requesting services and/or cell lines involving human cells must acknowledge that they have obtained all necessary permission from UPenn HUMAN STEM CELL RESEARCH ADVISORY COMMITTEE and have obtained all applicable IRB approval for research relating to human ESC/iPSC research.
  2. All materials (cells, tissues) delivered to the iPSC Core are not known or suspected to contain any infectious or etiologic agent.
  3. The investigator(s) requesting Services shall acknowledge the UPenn iPSC Core Facility in any publication resulting from services/cell lines provided by the Core.

iPSC Reprogramming & Characterization

Fibroblast isolation and expansion from skin biopsy

This service is normally requested in order to establish fibroblasts for iPSC reprogramming.

This service takes 3-4 weeks to complete and includes the following:

  • Fibroblast isolation from freshly collected skin biopsies
  • Establishment of fibroblast culture
  • Mycoplasma testing
  • Cryopreservation of several vials of early passage cells
  • Freezing of cell pellets for future RNA and DNA isolation

Live cultures will then be used for iPSC reprogramming

PBMC isolation from blood

This service is normally requested in order to isolate PBMCs from blood draws for iPSC reprogramming. 

Freshly isolated cells can be reprogrammed immediately or can be revived at a later time for iPSC reprogramming.  This service takes 1 day to complete and includes the following:

  • Isolation of PBMCs from blood using ficoll gradient separation
  • Cryopreservation of several vials of PBMCs at >4million cells per vial.
  • Freezing of cell pellets for future genomic DNA isolation

 Note:  This service does not include storage of cryopreserved vials in the Core facility

iPSC derivation from fibroblasts using Sendai virus

Prerequisites:

  • All required IRB approval must be in place. 
  • A Service Agreement must be completed for non-Penn users
  • The Core accepts either live or frozen cell stocks.
  • Submitted cells MUST be mycoplasma free before they are accepted.
  • Cells should also be at low passage (preferably <5) and are proliferating as non-dividing cells are refractory to reprogramming.

This service takes 4-6 months to complete and includes the following:

  • Expansion, mycoplasma testing, cryopreservation of fibroblast culture
  • Transduction of fibroblasts with Sendai viral reprogramming vectors
  • iPSC colony picking
  • Expansion of iPSC clones in feeder-free conditions
  • Mycoplasma testing of expanded clones
  • FACS analysis of 2 pluripotency markers
  • qPCR-based analysis for common karyotypic abnormalities in iPSCs
  • PCR assay for loss of Sendai viral reprogramming vectors
  • Cryopreservation of iPSC lines (4 vials/clone)
  • Will deliver 3 clones at passage ≥10

iPSC derivation from blood or PBMCs using Sendai virus

A minimum of 8 mls of blood is required for this service. Blood should be collected in CPT tube (BD biosciences) or other heparinized or EDTA tubes and delivered fresh to the Core. Please contact the Core director if you are submitting peripheral blood mononuclear cells (PBMCs).

Prerequisites:

  • All required IRB approval must be in place. Please submit IRB approval document here:
  • A Service Agreement must be completed for non-Penn users
  • Users should request the PBMC isolation from blood service or submit previously isolated PBMCs.
  • If submitting PBMCs, evidence showing their mycoplasma free status must be shown before they are accepted.

This service takes 4-6 months to complete and includes the following:

  • Culture of PBMCs for enrichment of erythroid progenitors
  • Transduction of cultured cells with Sendai viral reprogramming vectors
  • iPSC colony picking
  • Expansion of iPSC clones in feeder-free conditions
  • Mycoplasma testing of expanded clones
  • FACS analysis of 2 pluripotency markers
  • qPCR-based analysis for common karyotypic abnormalities in iPSCs
  • PCR assay for loss of Sendai viral reprogramming vectors
  • Cryopreservation of iPSC lines (4 vials/clone)
  • Will deliver 3 clones at passage ≥10

iPSC derivation from LCL cells using episomal vectors

Prerequisites:

  • All required IRB approval must be in place. 
  • A Service Agreement must be completed for non-Penn users.
  • When submitting LCL cells, evidence of their mycoplasma free status must be shown before they are accepted.

This service takes 4-6 months to complete and includes the following:

  • Culture of LCL cells for expansion
  • Neucleofection of cultured cells with Episomal reprogramming vectors
  • iPSC colony picking
  • Expansion of iPSC clones in feeder-free conditions
  • Mycoplasma testing of expanded clones
  • FACS analysis of 2 pluripotency markers
  • qPCR-based analysis for common karyotypic abnormalities in iPSCs
  • PCR assay for no genomic insertion of episomal reprogramming vectors
  • Cryopreservation of iPSC lines (4 vials/clone)
  • Will deliver 3 clones at passage ≥10

New iPSC line characterization-stem cell marker gene expression by qRT-PCR

Prerequisites:

  • Cell line must be generated by the Core

This service takes 1 week to complete and includes the following:

  • Isolation of total RNA from iPSC line
  • qRT-PCR analysis of 5 stem cell marker genes
  • Gene expression of parental cells and a previously established iPSC line included as controls
  • Will deliver analysis report

New iPSC line characterization-Tri-lineage differentiation and FACS analysis

Prerequisites:

 

  • Cell line must be generated by the Core

 

This service will take 3-4 weeks to complete and includes the following:

  • Expansion and plating of iPSC line for tri-lineage differentiation
  • Directed differentiation of iPSCs to mesoderm, endoderm and ectoderm lineages separately
  • Flow cytometry analysis of 2 marker proteins per cell lineage
  • Will deliver analysis report

iPSC line authentication by STR analysis

Prerequisites:

 

  • iPS Cell line must be generated by the Core
  • When submitting a non-iPSC line (i.e. parental cell line for iPSC derivation), user must submit a frozen cell pellet

 

This service will take 2-3 weeks to complete and includes the following:

  • Expansion of iPSC line
  • Freezing down of a cell pellet
  • Submission of frozen cell pellet to a commercial vendor for STR analysis
  • Delivery of STR analysis report

iPSC line karyotyping

Prerequisites:

  • Cell line must be generated by the Core

 This service will take 3-4 weeks to complete and includes the following:

  • Expansion of the iPSC line
  • Submission of live culture to a commercial vendor for G-banding of metaphase cells
  • Delivery of karyotyping report to the user

iPSC Expansion and Banking

Banking of feeder-dependent or feeder-independent cultures (20 vials)

This service provides thawing, expansion and banking of iPSC lines derived by the Core or external laboratories under feeder-dependent or feeder-free conditions.

Prerequisites:

  • Designation of iPSC line to be banked
  • iPSC lines new to the facility will need to produce evidence of being mycoplasma-free

This service takes 2-5 weeks to complete and includes the following:

  • Thaw cells on mouse feeders or under feeder-free conditions
  • Transition cells from feeder-dependent culture to feeder-free conditions if requested
  • Expansion of cells
  • Cryopreservation of expanded cells into 20 vials per cell line
  • Mycoplasma testing
  • Transfer of all frozen vials

Thawing and expansion of frozen iPSC cells (feeder-dependent or feeder-free)

This service provides thawing and expansion of iPSC line(s) with approved MTAs for one passage (~2 weeks) and delivers high quality undifferentiated cells (1 plate of 6-well plate) on mouse feeders or coated wells.

The lines need to be mycoplasma free.

Passaging iPSC cells

The service provides passaging feeder-free iPSC cells after thaw or transition from feeders every 5-7 days with routine maintenance.

Sendai virus loss check

This service will check whether the iPSCs reprogrammed by Sendai virus method still contain the virus.

  • Total RNA will be purified from the cells.
  • cDNA will be generated by reverse transcription with random primer.
  • Four sets of Sendai virus, reprogramming factor specific primer-probes together with a housekeeping set will be used in the qPCR.
  • Sendai virus loss will be decided when all 4 sets are undetectable with robust amplification of housekeeping gene.

Mycoplasma testing

This service provides genomic DNA extraction and PCR detection for mycoplasma from cell pellets.

Gene Editing in iPSCs

Gene knockout and deletion

This service establishes genome modified hESCs/hiPSCs using CRISPR/Cas9 technology

Prerequisites:

  • Selection of a hESC or hiPSC line to be gene edited
  • A Service Agreement must be executed for non-Penn users
  • MTA must be executed if transferring a cell line to the Core
  • All cell lines not generated by the Core must be shown evidence of being mycoplasma- free

This service takes 6-9 months to complete and includes the following:

  • Consultation with the user to determine targeting strategy
  • Design and construction of CRISPR gRNA(s) for targeting
  • Validation of gRNA(s) in the targeting cell line
  • Targeting of the cell line using validated gRNA(s)
  • Screening of targeted clones
  • Establishment of at least 2 correctly targeted clones
  • Mycoplasma testing of the clones
  • qPCR-based analysis for common karyotypic abnormalities of the clones
  • Delivery of cryopreserved cells and written report

Knock-in (plasmid donor template with antibiotic selection)

This service establishes genome modified hESCs/hiPSCs using CRISPR/Cas9 technology

Prerequisites:

  • Selection of a hESC or hiPSC line to be gene edited
  • A Service Agreement must be executed for non-Penn users
  • MTA must be executed if transferring a cell line to the Core
  • All cell lines not generated by the Core must be shown evidence of being mycoplasma- free

This service takes 6-9 months to complete and includes the following:

  • Consultation with the user to determine targeting strategy
  • Design and construction of CRISPR gRNA(s) for targeting
  • Validation of gRNA(s) in the targeting cell line
  • Targeting of the cell line using validated gRNA(s) and HDR DNA donor template
  • Screening of targeted clones
  • Establishment of at least 2 correctly targeted clones
  • Mycoplasma testing of the clones
  • qPCR-based analysis for common karyotypic abnormalities of the clones
  • Delivery of cryopreserved cells and written report

Knock-in (point mutation using ssODN as donor template)

This service establishes genome modified hESCs/hiPSCs using CRISPR/Cas9 technology

Prerequisites:

  • Selection of a hESC or hiPSC line to be gene edited
  • A Service Agreement must be executed for non-Penn users
  • MTA must be executed if transferring a cell line to the Core
  • All cell lines not generated by the Core must be shown evidence of being mycoplasma-free

This service takes 6-9 months to complete and includes the following:

  • Consultation with the user to determine targeting strategy
  • Design and construction of CRISPR gRNA(s) for targeting
  • Validation of gRNA(s) in the targeting cell line
  • Design and synthesis of the ssODN donor template
  • Targeting of the cell line using validated gRNA(s) and ssODN donor template
  • Screening of targeted clones
  • Establishment of at least 2 correctly targeted clones
  • Mycoplasma testing of the clones
  • qPCR-based analysis for common karyotypic abnormalities of the clones
  • Delivery of cryopreserved cells and written report

Design and construction of a donor template

This Service provides the design and the construction (cloning) of a plasmid template used for targeting iPSCs using homology directed repair (e.g. template for generating a gene reporter)

Prerequisites:

  • Selection of a hESC or hiPSC line to be gene edited
  • A Service Agreement must be executed for non-Penn users
  • MTA must be executed if transferring a cell line to the Core
  • All cell lines not generated by the Core must be shown evidence of being mycoplasma- free

This service takes 3-5 weeks to complete and includes the following:

  • Consultation with the user to determine targeting strategy
  • Design and construction of the donor vector
  • Delivery of the donor vector as a DNA maxiprep

Edited iPS Line Subcloning

Genotyping and sequencing

Next Generation Sequencing

Directed Differentiation of iPSCs

iPSC-derived cardiomyocytes

This service provides iPSC-derived cardiomyocytes in monolayer cultures.  iPSCs are differentiated using cytokines and small molecules in defined media.  Cultures are then metabolically selected to enrich for cardiomyocytes and re-plated. These cells resemble immature cardiomyocytes and but also display a number of properties of adult cardiomyocytes. 

Prerequisites:

  • Designation of iPSC line to be differentiated
  • New iPSC lines will need to show evidence of being mycoplasma-free or this will be performed by the Core at extra charge (see Mycoplasma Testing service)

This service takes 5-8 weeks to complete and includes the following:

  • Thaw cells and expand for differentiation
  • Up to two rounds of pilot studies to determine optimal seeding density and conditions for differentiation 
  • Directed differentiation in monolayer cultures
  • Transfer of live monolayer cultures of beating cells in two 10-cm plates
  • Approximate yield: 12-20 million cells

Additional Notes:

  • Additional plates can be purchased at a reduced price.
  • If differentiation fails in both pilot studies, PI will be notified immediately and the project will be discontinued.  Service fee still applies.
  • More pilot studies can be performed using a different CM differentiation protocol after submitting a new request.

iPSC-derived pulmonary Alveolar Type 2 cells (iAT2s)

This service provides iPSC-derived pulmonary alveolar type 2 cells (iAT2s) derived from the BU-SPC2-ST-B2 line (Boston University).  Cells were differentiated and maintained as alveolospheres embedded in 3D Matrigel as previously described (Jabob et al., 2019) and passaged every two weeks.  The iAT2s express the tdTomato fluorescent marker protein from the endogenous locus of surfactant protein-C (SFTPC).  tdTomato expression is assayed by flow cytometry as each passage and should be between 50-90%.

This service takes 2-4 weeks to complete and will be provided in single cell suspensions in growth media or plated in 2D format.  One unit = 10 millions cells. 

Additional Notes:

  • If cell expansion fails or tdTomato expression is suboptimal, the PI will be notified immediately.
  • Additional units of cells can be purchased, but at least 2 week advance notice is required.

iPSC-derived Hepatocyte Like Cells (HLCs)

This service provides HLCs in monolayer cultures.   iPSCs undergo stage-specific directed differentiation to establish definitive endoderm followed by, hepatic progenitors, immature hepatocytes, and hepatocyte-like cells (HLCs).  These cells resemble fetal hepatocytes but do display a number of properties of mature hepatocytes.

Prerequisites: 

  • Designation of iPSC line to be differentiated
  • New iPSC lines will need to show evidence of being mycoplasma-free

This service will take 5-8 weeks to complete and includes the following:

  • Thaw cells and expand for differentiation
  • Pilot study to determine optimal seeding density for differentiation (if working with new line)
  • Directed differentiation in monolayer cultures
  • Flow cytometry analysis of definitive endoderm markers (Sox17/CXCR4) at day 5 and flow cytometry analysis of albumin on day 20
  • Transfer of live, monolayer culture supplied in either four 6-well plates or four 12-well plates (approx. 25,000 cells/cm2)

Additional Notes:

  • If differentiation fails, PI will be notified immediately
  • Additional plates can be generated at a reduced price

iPSC-derived endothelial cells

This service provides iPSC-derived endothelial cell in monolayer cultures.  iPSCs undergo directed differentiation using cytokines and small molecules to endothelial progenitors.   Cultures are then purified with endothelial specific cell surface markers to enrich for purity and further passaged.  These cells express CD31(PECAM) & CD144 (VE-cadherin) surface markers, uptake Ac-LDL, and form vessels when cultured with stromal cells in 3D cultures.

Prerequisites:

  • Designation of iPS line to be differentiated
  • New iPSC lines will need to show evidence of being mycoplasma-free

This service takes 4-6 weeks to complete and includes the following:

  • Thaw cells and expand for differentiation
  • Directed differentiation in monolayer cultures
  • Magnetic activated cell sorting against endothelial markers
  • Passaged in endothelial growth media for cell expansion
  • Flow cytometry analysis of endothelial markers CD31/CD144
  • Passage 3 live culture supplied in at least 2 6-well plates
  • Approximate yield: 6 million cells
  • Guaranteed purity > 90% CD31+/CD144+

Additional Notes:

  • If differentiation fails, PI will be notified immediately
  • Additional plates can be purchased at a reduced price

iPS-derived Retinal Pigmented Epithelial cells (RPE)

iPS-derived adipocytes

Hands-on Training Course in iPSC culture

Hands-on Training Course

Prerequisites:

  • Students must have at least one year of hands-on experience in mammalian cell culture

This is a hands-on training course in basic techniques in hESC/iPSC culture including cell thawing, expansion, identification by morphology, manual and enzymatic passaging, freezing, and feeder-free culture.  This course will take 2 weeks to complete (1-2 hours per day)

Cell Lines and Tissue Culture Reagents

iPSC line request

The Core has a number of wild-type control iPSC lines available to users.   Please inquire with the Core director at wenliyan@pennmedicine.upenn.edu.

Tissue Culture Reagents

The iPSC Core offers a number of quality-tested reagents and for use in stem cell culture. For pricing and a full list of reagents, please visit the iPS Core iLab website.